Quest Diagnostics Inc
DGXNYSECIK 1022079HealthcareFiscal year ends Dec 31
All transactions: 7
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Pfeiffer Gary MDirector | Sale | 1,203 | $243.00 | $292.3k | Form 4 |
| 2026-10-21 | Kuppusamy KarthikSVP, Clinical Solutions, Officer | Code L | 33 | $235.944 | $7.8k | Form 4 |
| 2026-10-21 | Gregg Vicky BDirector | Grant or award | 63 | $235.939 | $14.9k | Form 4 |
| 2026-10-21 | Delaney Mark ESVP & Chief Commercial Officer, Officer | Code L | 25 | $235.941 | $5.9k | Form 4 |
| 2026-10-21 | Main Timothy LDirector | Code L | 18 | $235.937 | $4.2k | Form 4 |
| 2026-10-21 | Plewman PatrickSVP for Diagnostic Services, Officer | Code L | 41 | $235.94 | $9.7k | Form 4 |
| 2026-10-21 | Lassiter Wright IIIDirector | Code L | 6 | $235.959 | $1.4k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 04:31 ET. Listed shows no prices and gives no investment advice.